MedAvail Holdings, Inc. Common Stock
MDVL
MDVL was delisted on the 12th of February, 2024.
6 hedge funds and large institutions have $140K invested in MedAvail Holdings, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 6 → 6 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
31% less capital invested
Capital invested by funds: $202K → $140K (-$62K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RMAM
Raab & Moskowitz Asset Management
Chatham,
New Jersey
|
+$2.38K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$16.6K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.71K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$4K |
MDVL Hedge Fund Activity: Q3 2018 in Review
6 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in MedAvail Holdings, Inc. Common Stock (MDVL) for Q3 2018, worth a combined $140K — down 31% from $202K a quarter earlier.
Fund positioning in MDVL was balanced in Q3 2018: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 2 trimmed.
The largest buyer was Raab & Moskowitz Asset Management, opening a new position worth an estimated $2.38K. The largest seller was Citadel Advisors, cutting an estimated $16.6K.
- 6 institutional investors held MedAvail Holdings, Inc. Common Stock (MDVL) as of Q3 2018, unchanged from Q2 2018.
- Funds reported $140K of MedAvail Holdings, Inc. Common Stock stock for Q3 2018, down 31% quarter-over-quarter.
- 1 fund opened new MedAvail Holdings, Inc. Common Stock positions in Q3 2018 and 1 closed out, a net change of 0 holders.
- The largest MedAvail Holdings, Inc. Common Stock buyer in Q3 2018 was Raab & Moskowitz Asset Management, an estimated $2.38K added.
- The largest MedAvail Holdings, Inc. Common Stock seller in Q3 2018 was Citadel Advisors, an estimated $16.6K sold.
Based on aggregated 13F filings for Q3 2018.